Cocrystal Pharma earnings were -$12.6M for the trailing 12 months ending Jun 30, 2025, with N/A growth year over year. The latest COCP earnings report on Jun 30, 2025 announced Q2 2025 earnings of -$2.1M, down 10.7% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, COCP reported annual earnings of -$17.5M, with -2.7% growth.
What were Cocrystal Pharma's earnings last quarter?
Cocrystal Pharma (NASDAQ: COCP) reported Q2 2025 earnings per share (EPS) of -$0.20, up 62.26% year over year. Total COCP earnings for the quarter were -$2.06 million. In the same quarter last year, Cocrystal Pharma's earnings per share (EPS) was -$0.53.
As of the last Cocrystal Pharma earnings report, Cocrystal Pharma is currently losing money. Cocrystal Pharma's net profit (also called net income) for the twelve months ending Jun 30, 2025 was -$12.56 million, a 29.94% decrease year over year.
What was COCP's earnings growth in the past year?
As of Cocrystal Pharma's earnings date in Q3 2025, Cocrystal Pharma's earnings has grown year over year. COCP earnings in the past year totalled -$12.56 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.